A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf
.
Circulating tumor DNA: a noninvasive biomarker for tracking ovarian cancer
2021
Reproductive Biology and Endocrinology
AbstractOvarian cancer is the fifth leading cause of cancer-related mortality in women worldwide. Despite the development of technologies over decades to improve the diagnosis and treatment of patients with ovarian cancer, the survival rate remains dismal, mainly because most patients are diagnosed at a late stage. Traditional treatment methods and biomarkers such as cancer antigen-125 as a cancer screening tool lack specificity and cannot offer personalized combinatorial therapy schemes.
doi:10.1186/s12958-021-00860-8
pmid:34861867
pmcid:PMC8641226
fatcat:awx7p3fgjndeteoi2gvsvgu4wq